Government plans to cap stent prices Rs 20,000 onwards

The government has been mulling over this proposal, and continues to receive a strong support from key ministries like health and commerce besides the department of pharmaceuticals.

The National Health Systems Resource Centre (NHSRC), a technical support institution under the health ministry, has also supported the cause by recommending the National Pharmaceutical Pricing Authority (NPPA), to make a quick decision to stop overcharging consumer in absence of any regulations.

Another concerning issue raised by NPPA is the huge gap between the price of imported stents (which constitute 70-80% of medical devices in India) and locally manufactured ones.

The final decision is now awaited in January with the proposal being in its final stages and still awaiting approval from a core committee on essential medicines.

Also read: Govt mulls controlling prices of medical equipment

As reported by TOI, "We have come up with a revised list of essential medicines following the core-committee's recommendations. The same committee is also examining the matter of coronary stents and will come up with a supplementary report very soon," a senior official at the drug regulator's office said.

He added that the proposal to cap prices of stents was on hold for long as there was pressure to create a separate law for medical devices. However, for now, the health ministry has created a separate chapter under the Drugs and Cosmetics (Amendment) Bill, 2015 which classifies medical devices as per their use in primary, secondary and tertiary care.

According to the official, since both medicines and medical devices are governed under the same law, the list of essential medicines can also include other essential commodities like stents which are frequently used for public health and are often priced exorbitantly.